The Latest in HCV Hub

All-oral simeprevir-sofosbuvir beat interferon-based regimen for HCV with compensated cirrhosis

April 1, 2015

New hepatitis treatment cost effective for some patient types

March 30, 2015

FDA: Avoid using amiodarone with some hepatitis C antivirals

March 24, 2015

Novel HCV therapies found cost effective, with caveats

March 16, 2015

ASCEND trial to test HCV treatment in primary care setting

March 7, 2015

Case studies highlight HCV health care transmission risk

February 27, 2015

Death rates rising for liver cancer, falling for colorectal cancer

February 24, 2015

Two regimens achieve high response in HCV/HIV coinfection

February 23, 2015

Threefold increase in cirrhosis risk with HCV

February 4, 2015

Human liver cells can induce antiviral reaction against hepatitis C

February 1, 2015

HCV continuum critical to providing better care in urban areas

January 25, 2015

Measures predict outcomes of chronic HCV with compensated cirrhosis

January 21, 2015

Hepatitis

Sofosbuvir and ribavirin effective in transplant patients with compensated recurrent HCV

January 20, 2015

Hepatitis

Sofosbuvir and ribavirin prevent HCV recurrence after liver transplantation

January 20, 2015

Hepatitis

Aetna customers to receive discount on Gilead’s hepatitis C treatment

January 16, 2015